Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 6 de 6
Filter
1.
Diabetes Obes Metab ; 18(1): 40-8, 2016 Jan.
Article in English | MEDLINE | ID: mdl-26343931

ABSTRACT

AIM: To evaluate, using post hoc analyses, whether the novel combination of a basal insulin, insulin degludec, and a glucagon-like peptide-1 receptor agonist, liraglutide (IDegLira), was consistently effective in patients with type 2 diabetes (T2D), regardless of the stage of T2D progression. METHODS: Using data from the DUAL I extension [insulin-naïve patients uncontrolled on oral antidiabetic drugs (OADs), n = 1660, 52 weeks] and DUAL II (patients uncontrolled on basal insulin plus OADs, n = 398, 26 weeks) randomized trials, the efficacy of IDegLira was investigated with regard to measures of disease progression stage including baseline glycated haemoglobin (HbA1c), disease duration and previous insulin dose. RESULTS: Across four categories of baseline HbA1c (≤7.5-9.0%), HbA1c reductions were significantly greater with IDegLira (1.1-2.5%) compared with IDeg or liraglutide alone in DUAL I. In DUAL II, HbA1c reductions were significantly greater with IDegLira (0.9-2.5%) than with IDeg in all but the lowest HbA1c category. In DUAL I, insulin dose and hypoglycaemia rate were lower across all baseline HbA1c categories for IDegLira versus IDeg, while hypoglycaemia was higher with IDegLira than liraglutide, irrespective of baseline HbA1c. In DUAL II, insulin dose and hypoglycaemia rate were similar with IDegLira and IDeg (maximum dose limited to 50 U) independent of baseline HbA1c. The reduction in HbA1c with IDegLira was independent of disease duration and previous insulin dose but varied depending on pre-trial OAD treatment. CONCLUSIONS: IDegLira effectively lowered HbA1c across a range of measures, implying suitability for patients with either early or advanced T2D.


Subject(s)
Diabetes Mellitus, Type 2/drug therapy , Glycated Hemoglobin/analysis , Hypoglycemic Agents/administration & dosage , Insulin, Long-Acting/administration & dosage , Liraglutide/administration & dosage , Aged , Diabetes Mellitus, Type 2/blood , Drug Therapy, Combination , Female , Glycated Hemoglobin/drug effects , Humans , Hypoglycemia/chemically induced , Male , Metformin/administration & dosage , Middle Aged , Randomized Controlled Trials as Topic , Time Factors , Treatment Outcome
2.
J Clin Epidemiol ; 60(9): 954-62, 2007 Sep.
Article in English | MEDLINE | ID: mdl-17689812

ABSTRACT

OBJECTIVE: To investigate whether immediate effects of a 3-year educational intervention in primary health care were confirmed 18 months after the end of the intervention. STUDY DESIGN AND SETTING: A controlled 3-year intervention study in 34 Danish municipalities with randomization and intervention at municipality level. The 17 intervention municipality visitors received regular education, and GPs were introduced to a short assessment program. The effect was measured at the individual level by questions about functional ability at the end of the intervention period and 1(1/2) years later; 4,060 older adults living in the municipalities participated. We adopt the approach introduced by Dufouil et al. (2004) and treat dropouts due to death differently from dropouts from other reasons. RESULTS: Educational intervention to primary care professionals was associated with better functional ability in surviving women at the end of the intervention (odds ratio [OR]: 1.24, 95% confidence interval [CI]=1.07-1.45), from the end of the intervention until 1(1/2) years later (OR: 1.21, 95% CI=1.03-1.44) and during the total study period (OR: 1.22, 95% CI=1.06-1.42). No effects were seen in men. CONCLUSION: The effect of a brief, feasible educational intervention for primary care professionals is sustained in women 1(1/2) years after the end of the intervention.


Subject(s)
Health Promotion/methods , House Calls , Activities of Daily Living , Aged , Community Health Nursing/education , Denmark , Education, Continuing , Female , Health Services for the Aged , Humans , Longitudinal Studies , Preventive Health Services , Program Evaluation
3.
Acta Psychiatr Scand ; 114(3): 168-76, 2006 Sep.
Article in English | MEDLINE | ID: mdl-16889587

ABSTRACT

OBJECTIVE: To compare the temporal changes in suicide rate among patients treated with antidepressants with the change in suicide rate among persons who have not been treated with antidepressants during 1995-1999. METHOD: In a historic prospective national pharmacoepidemiological register linkage study by using four Danish registers we included 438,625 patients who had purchased antidepressants, and compared them with 1,199,057 population based control persons. The annual rate of suicide was estimated using Poisson regression analyses. RESULTS: The suicide rate decreased for persons treated with antidepressants as well as for persons not treated with antidepressants. The proportion of persons, who committed suicide and who had not been treated with antidepressants decreased. The reduction in suicide rate was more pronounced among persons treated with SSRIs or older antidepressants than among persons not treated with antidepressants. CONCLUSION: Several factors contribute to the decreasing suicide rate. The most pronounced decrease in suicide rate was found among persons treated with antidepressants.


Subject(s)
Depressive Disorder/drug therapy , Suicide/trends , Adolescent , Adult , Aged , Aged, 80 and over , Cause of Death , Cross-Sectional Studies , Denmark , Depressive Disorder/mortality , Drug Utilization Review , Female , Humans , Male , Middle Aged , Prospective Studies , Registries , Selective Serotonin Reuptake Inhibitors/therapeutic use , Suicide Prevention
4.
J Neurol Neurosurg Psychiatry ; 77(6): 781-3, 2006 Jun.
Article in English | MEDLINE | ID: mdl-16705201

ABSTRACT

OBJECTIVE: To estimate the risk for persons treated with antidepressants or lithium of subsequent treatment with antiparkinson drugs (APD). METHODS: The Danish national prescription database supplied data on all persons who received antidepressants, lithium, or antidiabetics (first control group). A second control group was included comprising persons from the general population. Outcome was purchase of APD and the study period was 1995 to 1999. RESULTS: In total, 1 293 789 persons were included. The rate ratio of treatment with APD after treatment with antidepressants was 2.27 (95% CI 2.14 to 2.42) for men and 1.50 (95% CI 1.43 to 1.58) for women. Figures for lithium were almost identical. CONCLUSION: Persons treated with antidepressants or lithium are at increased risk of subsequently treatment with APD, showing an association between anxiety/affective disorder and Parkinson's disease.


Subject(s)
Antidepressive Agents/therapeutic use , Antimanic Agents/therapeutic use , Antiparkinson Agents/therapeutic use , Lithium Carbonate/therapeutic use , Parkinson Disease/epidemiology , Anxiety Disorders/complications , Case-Control Studies , Denmark/epidemiology , Drug Prescriptions/statistics & numerical data , Epidemiologic Studies , Female , Humans , Male , Mood Disorders/complications , Parkinson Disease/drug therapy , Parkinson Disease/etiology , Parkinson Disease/physiopathology , Pharmacoepidemiology , Risk Factors
5.
Hum Reprod ; 21(2): 484-91, 2006 Feb.
Article in English | MEDLINE | ID: mdl-16210383

ABSTRACT

BACKGROUND: Boys with cryptorchidism often face fertility problems in adult life despite having orchiopexy performed at a very young age. During this operation, a biopsy of the testis is normally taken in order to evaluate their infertility potential and the presence of malignant cells. This study evaluated the morphology and functional capacity of cryopreserved testes biopsies and their possible use in fertility preservation. METHODS: Biopsies from 11 testes (eight boys) were obtained. Each biopsy was subdivided into six pieces and two pieces were frozen in each of two different cryoprotectants. One fresh and two cryopreserved pieces were cultured for 2 weeks. All pieces were prepared for histology. Used culture media were analysed for testosterone and inhibin B concentrations. RESULTS: The morphology of the fresh and frozen-thawed samples was similar, with well-preserved seminiferous tubules and interstitial cells. A similar picture appeared after 2 weeks of culture, but a few of the cultured biopsies contained small necrotic areas. The presence of spermatogonia was verified by c-kit-positive immunostaining. Production of testosterone and inhibin B (ng/mm(3) testis tissue) in the frozen-thawed pieces was on average similar to that of the fresh samples. CONCLUSIONS: Intact testicular tissue from young boys with non-descended testes tolerates cryopreservation with surviving spermatogonia and without significant loss of the ability to produce testis-specific hormones in vitro. It may be an option to freeze part of the testis biopsy, which is routinely removed during the operation for cryptorchidism, for fertility preservation in adult life.


Subject(s)
Cryopreservation/methods , Cryptorchidism/pathology , Testis , Biopsy , Child , Child, Preschool , Cryptorchidism/surgery , Humans , Infant , Inhibins/metabolism , Male , Testis/metabolism , Testis/pathology , Testosterone/metabolism , Tissue Culture Techniques
6.
Ugeskr Laeger ; 161(44): 6059-60, 1999 Nov 01.
Article in Danish | MEDLINE | ID: mdl-10778343

ABSTRACT

Eosinophilic cystitis is an inflammatory disorder of the urinary bladder, characterised by irritative voiding symptoms, negative urine cultures, and eosinophilic infiltration of the bladder wall. Since 1960 only about 20 cases have been described in the English scientific reports, making it a rather rare entity. In children the disease appears to be shortlived and self-limited, requiring no specific treatment. We present a case with a 7.5-year-old boy, who experienced spontaneous remission of all symptoms, following an acute attack of eosinophilic cystitis.


Subject(s)
Cystitis , Eosinophils , Child , Cystitis/diagnostic imaging , Cystitis/pathology , Humans , Male , Radiography , Urinary Bladder/diagnostic imaging , Urinary Bladder/pathology
SELECTION OF CITATIONS
SEARCH DETAIL
...